In SOMAprobes we have a multidisciplinary team formed by the founding partners, executives with extensive experience in business development in the area of Biotechnology and a group of scientists with an important background in Biotechnology and Chemistry dedicated to the R&D of the company.
SOMAprobes leverages its knowledge about the biochemistry of nucleases and oligonucleotides substrates to develop products that combine specificity, sensitivity and speed, with innovative properties, such as the possibility of measuring the biological activity of the pathology in situ. By optimising these features, SOMAprobes aims to generate tools with properties beyond the reach of existing technologies for use in a wide range of applications, starting with more sensitive diagnostic kits for sepsis, coronavirus and other human conditions, such as cancer.
Chief Executive Officer
Eduardo has a MsC in Civil Engineering from Polytechnical University Madrid (UPM) and an MBP, PDD from IESE Business School. He has expertise in data management with training in Executive Data Science Specialization from John Hopkins University. Eduardo is entrepreneur and team leader creating new businesses and making big transformations in complex organizations, leading people with different skills and cultures, bringing success to people.
He was the CEO of PlantResponse Biotech where he raised 13 m€ Series A, B and Founder of Inhibitec Anticuerpos and FAIR Data Systems. He is currently acting as the CEO of SOMAprobes, bringing to the table his skills of negotiation in complex businesses, fundraising and deals, team leadership, and business strategy definition.
Luiza I. Hernandez
Chief Technology Officer
Luiza has an MS from Eastern Michigan University (USA) and a PhD in Chemistry focused on bioanalytical applications from Michigan State University (USA). Luiza has sound background in science and biomedical field, with extensive international experience as postdoctoral researcher in USA, The Netherlands, Sweden and Spain.
She brings more than 10 years of expertise spanning the fields of chemistry, biology, microfluidics, RNA-based technologies for diagnostics and therapeutics, and biomarker discovery. Luiza is an expert in nucleases as biomarkers of disease (cancer and infectious diseases) and nuclease-based diagnostic technologies. She leads SOMAprobes`s research and development efforts to commercialize the nuclease-based technology applications and she oversees all day-to-day R&D operations. Luiza is co-inventor of the company´s core technology, author of 7 patent applications and more than 15 publications in high impact factor journals.
Frank J. Hernandez
Chief Scientific Officer
Frank received his PhD in Bioengineering from University Rovira i Virgili (Spain). He is formed as microbiologist, with extensive international training in biosensing (Spain), chemical modifications of nucleic acids (Denmark) for diagnostics and therapeutic applications (USA, Sweden).
He is co-founder of SOMAprobes and represents the scientific goals and interests of the company. He oversees the company´s intellectual property, all matters related to company’s technology, its applications, and clinical protocols. He manages collaborations with hospitals and universities.
Frank is co-inventor of the company´s core technology and author of numerous patents and more than 25 publications in high impact factor scientific journals. Currently, Frank is assistant professor at Linkoping University (Sweden). He is the Group Leader of the Nucleic Acids Technology lab (NAT-lab) and a fellow of the Wallenberg Centre for Molecular Medicine (WCMM), Sweden.
Miguel is a consultant and advisor to large pharma and biotech companies in Europe and the US. Previously he was Director of Strategy and Corporate Development at TiGenix acquired by Takeda in 2018 and held managerial positions at Genetrix and J&J in Europe.
He co-founded Mirada Solutions, one of Oxford University’s most successful spin-offs that became Siemens Molecular and more recently joined the founders of SOMAprobes where he is currently providing advice on its business development strategy. Miguel has a PhD in Medical Imaging and an MBA from the University of Oxford and an MEng from Imperial College, London.
Isabel has obtained her PhD in Applied Chemistry and Polymeric Materials by the University of the Basque Country (UPV/EHU), Spain. Her expertise includes nucleic acid selection and detection systems, as well as extensive experience in microbiology and molecular biology techniques.
Isabel joined SOMAprobes shortly after its foundation, helping the founders to build the portfolio of applications of SOMAprobes’ technology. Thus, she has extensive expertise in the development of projects, establishing the protocols for detecting nuclease activity for a variety of clinical tissues and biological samples, work that is reflected in publications that she authored in high impact international scientific journals. Currently, Isabel is in charge of general laboratory tasks and is also a mentor for university students who choose to have their research experience in the technology and laboratory of SOMAprobes.
Tania Jimenez Trujillo
Synthesis Project Manager
Tania has obtained her PhD in Organic Chemistry from the University of Granada (Spain). She has extensive expertise in chemical synthesis that she built during several international postdoctoral experiences, such as Marie Skłodowska-Curie Fellow at the…
University of Göteborg (Sweden, 2015-2017), postdoctoral researcher at Antwerp University (Belgium, 2015) and at ICIQ (Spain, 2013), and visiting researcher at Harvard University (USA, 2011).
In SOMAprobes, Tania is in charge of the chemical synthesis of oligonucleotide probes and of active compounds for diagnostic applications. She has authored more than 10 publications in international scientific journals.
Lorena Pazos Vegas
Quality and Regulatory Affairs Manager
Lorena has a Bachelor of Science in Marine Biology from University of Wales (UK), a Master in Cosmetics and Dermopharmacy (CESIF), Madrid and a Master in Integrated Management of Quality, Environment and PRL Systems. Throughout her professional career she has…
gained extensive experience in quality management in different fields such as the pharmaceutical industry, biotechnology, medical devices, etc.
Lorena will direct and manage all aspects of the quality assurance strategy and regulatory compliance function of the company and the products that SOMAprobes manufactures.
Garazi Goikoetxea Abad
Junior Scientist – PhD student
Garazi has obtained a Bachelor of Science Degree in Chemistry and a Master in Master in Biomedical Research from ‘University of Basque Country’ (UPV/EHU).
She is currently pursuing an industrial PhD programme in SOMAprobes. Her main activities are focused on research and development of products for the diagnosis of infectious diseases. (NuCor).
Enara Alday Echechipia
Junior Scientist – Master student
Enara has obtained a Bachelor of Science Degree in Chemistry from ‘University of Basque Country’ (UPV/EHU).
Currently she is pursuing a Master in Chemistry and Polymers from the University of Basque Country (UPV/EHU) in collaboration with SOMAprobes. Her main activities are focused on research and development of products for the diagnosis of sepsis (NuSep project).
Jon Martin Susperregui
Jon is an undegraduate student in the ‘Faculty of Chemistry’ at the University of Basque Country (UPV) and he is currently conducting his thesis project at SOMAprobes.
Jobs and traineeships
If you would like to work with us, send us your resume to: email@example.com